TVARDI THERAPEUTICS, INC. Shareholders' Equity
TVARDI THERAPEUTICS, INC. (TVRD) had Shareholders' Equity of $8.38 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $8.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $14.51M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $20.95M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $27.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $8.38M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $14.51M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $20.95M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $27.87M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $32.93M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$100.63M 10-Q · filed 2026-08-14 | -$8.07M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$91.13M 10-Q · filed 2026-08-14 | -$4.59M 10-K · filed 2025-03-11 |
| 2024-09-30 | -$78.50M 10-Q · filed 2025-11-13 | $707.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$73.07M 10-Q · filed 2025-11-13 | $11.60M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$66.17M 10-Q · filed 2025-11-13 | $29.80M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$62.06M 10-K · filed 2026-03-31 | $57.09M 10-K · filed 2024-03-06 |
| 2023-09-30 | $85.64M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $108.93M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $136.60M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $158.78M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $184.82M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $204.42M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $204.12M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $227.52M 10-K · filed 2025-03-11 | |
| 2021-09-30 | $207.19M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $203.47M 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $230.46M 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $249.00M 10-K · filed 2024-03-06 | |
| 2020-09-30 | $127.85M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $140.93M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $160.47M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $186.71M 10-K · filed 2023-03-06 | |
| 2019-09-30 | $211.89M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $99.55M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $114.52M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $133.63M 10-K · filed 2022-03-01 | |
| 2018-09-30 | $149.53M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $73.08M 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $72.10M 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $86.78M 10-K · filed 2021-02-25 | |
| 2017-09-30 | $99.07M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $109.22M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $29.27M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $50.73M 10-K · filed 2020-02-27 | |
| 2016-09-30 | $71.80M 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $82.59M 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $94.93M 10-Q · filed 2017-05-04 | |
| 2015-12-31 | $105.04M 10-K · filed 2019-03-12 | |
| 2015-09-30 | $113.86M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $42.47M 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $47.42M 10-Q · filed 2016-05-05 | |
| 2014-12-31 | $51.66M 10-K · filed 2018-03-15 | |
| 2014-09-30 | $55.34M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $61.57M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $64.73M 10-Q · filed 2015-05-12 | |
| 2013-12-31 | -$54.08M 10-K · filed 2017-03-10 | |
| 2013-09-30 | -$51.99M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$48.43M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | -$55.27M 10-Q · filed 2014-05-12 | |
| 2012-12-31 | -$58.13M 10-K · filed 2016-03-11 | |
| 2011-12-31 | -$52.06M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |